✦ LIBER ✦

Cyclophosphamide/doxorubicin/prednisone/vincristine

Book ID: 125390204
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 219 KB
Volume: 1505
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-014-1340-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Posttransplantation lymphoproliferative

Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy

✍ T. J. Garrett; Ronald E. Drusin; Larry L. Schulman; Dennis S. Reison; Amy Chadbu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Cyclophosphamide, doxorubicin, vincristi

Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma

✍ R. I. Fisher 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 109 KB

Absolute monocyte count in follicular ly

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

✍ Watanabe, Reina; Tomita, Naoto; Kishimoto, Kumiko; Koyama, Satoshi; Ogusa, Eriko 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 612 KB

Activity of Rituximab plus Cyclophospham

Activity of Rituximab plus Cyclophosphamide, Doxorubicin/Mitoxantrone, Vincristine and Prednisone in Patients with Relapsed MALT Lymphoma

✍ Raderer, Markus; Wöhrer, Stefan; Streubel, Berthold; Drach, Johannes; J&aum 📂 Article 📅 2006 🏛 S. Karger AG 🌐 English ⚖ 155 KB

Heterogeneity of response and survival i

Heterogeneity of response and survival in diffuse histiocytic lymphoma after bacop therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone)

✍ Alexandra M. Levine; Mark Goldstein; Paul R. Meyer; Stephen J. Forman; John W. P 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 884 KB

Chemotherapy with etoposide, vincristine

Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma

✍ Gorgun Akpek; Howard K. Koh; Steven Bogen; Carl O'Hara; Francine M. Foss 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL). ## METHODS. Fifteen patients were tre